Bioprosthetic mitral transcatheter transapical valve-in-valve implantation for mitral stenosis in an end-stage renal disease patient

Kongkiat Chaikriangkrai, Rajiv Goswami, Stephen Little, Su Min Chang, Basal Ramlawi, Hye Yeon Jhun, Neal Kleiman, Michael J. Reardon, Colin Barker

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Transcatheter mitral valve-in-valve implantation (TMVIV) is an option for patients with mitral prosthetic valve dysfunction who are at high risk for surgical valve replacement. Efficacy and safety of TMVIV is at its infancy. We report a high-risk symptomatic dialysis-dependent end-stage renal disease patient with severe bioprosthetic mitral valve stenosis who had TMVIV performed successfully.

Original languageEnglish (US)
Pages (from-to)697-700
Number of pages4
JournalJournal of cardiac surgery
Volume30
Issue number9
DOIs
StatePublished - Sep 1 2015

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Bioprosthetic mitral transcatheter transapical valve-in-valve implantation for mitral stenosis in an end-stage renal disease patient'. Together they form a unique fingerprint.

Cite this